Plain-English translation of NCT05051579 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial examined whether a new medication called could help people lose weight and manage health conditions related to obesity, such as high blood pressure or high cholesterol. Researchers studied different doses of the medication to find which one worked best and was safest. Participants took the medication by mouth once a day for nine months.
Current treatments for obesity are limited, and many people struggle to lose weight with diet and exercise alone. This trial aimed to test whether this medication could offer a new option for people who are overweight or obese and have related health problems.
Participants received the medication as a daily oral pill for 36 weeks (about nine months). The dose was gradually increased over several weeks until reaching the target maintenance dose assigned to their group, then remained at that dose for the remainder of the study. Participants would have attended clinic visits for monitoring and to receive their medication refills.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
United States